Luis Sánchez-Pérez
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 52
- Immunotherapy and Immune Responses 44
- T-cell and B-cell Immunology 13
- Immune Cell Function and Interaction 11
- Oncology 49
- CAR-T cell therapy research 41
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- John H. Sampson (48 shared papers)James E. Herndon (19 shared papers)Darell D. Bigner (14 shared papers)Bryan D. Choi (17 shared papers)Gary E. Archer (13 shared papers)Duane A. Mitchell (12 shared papers)Carter M. Suryadevara (17 shared papers)Elizabeth A. Reap (12 shared papers)
- Journals
- Clinical Cancer Research (8 papers)OncoImmunology (8 papers)Blood (5 papers)Cancer Research (5 papers)Neuro-Oncology (5 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Luis Sánchez-Pérez
76 papers receiving 4.1k citations
Luis Sánchez-Pérez's Hit Papers
Peers
Comparison fields: 5 of 96
- Immunology 2.2k
- Oncology 2.3k
- Genetics 775
- Genetics 608
- Molecular Biology 1.1k
Countries citing papers authored by Luis Sánchez-Pérez
This map shows the geographic impact of Luis Sánchez-Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Sánchez-Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Sánchez-Pérez more than expected).
Fields of papers citing papers by Luis Sánchez-Pérez
This network shows the impact of papers produced by Luis Sánchez-Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Sánchez-Pérez. The network helps show where Luis Sánchez-Pérez may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Sánchez-Pérez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients Hit paper breakdown → | 2015 | 433 |
| 2 | 2009 | 322 | |
| 3 | 2019 | 252 | |
| 4 | 2013 | 251 | |
| 5 | 2017 | 251 | |
| 6 | 2010 | 215 | |
| 7 | 2009 | 170 | |
| 8 | 2005 | 128 | |
| 9 | 2012 | 115 | |
| 10 | 2007 | 111 | |
| 11 | 2004 | 100 | |
| 12 | 2011 | 99 | |
| 13 | 2014 | 98 | |
| 14 | 2013 | 94 | |
| 15 | 2018 | 88 | |
| 16 | 2016 | 79 | |
| 17 | 2011 | 77 | |
| 18 | 2005 | 76 | |
| 19 | 2007 | 72 | |
| 20 | 2008 | 68 |
About Luis Sánchez-Pérez
Luis Sánchez-Pérez is a scholar working on Immunology, Oncology, Molecular Biology, Biomedical Engineering and Genetics, having authored 77 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (44 papers), CAR-T cell therapy research (41 papers), T-cell and B-cell Immunology (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Immune Cell Function and Interaction (11 papers), Nanowire Synthesis and Applications (10 papers), Glioma Diagnosis and Treatment (10 papers) and RNA Interference and Gene Delivery (8 papers). The work is most often cited by research in Immunology (2.2k citations), Oncology (2.3k citations), Genetics (775 citations), Genetics (608 citations) and Molecular Biology (1.1k citations). Luis Sánchez-Pérez has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include John H. Sampson, James E. Herndon, Darell D. Bigner, Bryan D. Choi, Gary E. Archer, Duane A. Mitchell, Carter M. Suryadevara, Elizabeth A. Reap, William H. Tomaszewski and Pawel Muranski. Their work appears in journals such as Clinical Cancer Research, OncoImmunology, Blood, Cancer Research and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.